Skip to main content

Chris Murray

Physician and health economist; founder and director of the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, lead of the Global Burden of Disease study.

Oct 5, 2026

7:11
So what will they be able to see in the data in 2030, for example, that they can't see today?
7:17
So what we've learned along the way in the now 35 years of the Global Burden of Disease work is initially that started out at a regional level when it was done for the World Bank in 1991 to 93.
7:34
Then it became country specific when it was based at WHO.
7:40
And then in the last 20 years, where it's been based at the Institute for Health Metrics and Evaluation, We have been able to, where certain countries have asked for it, we've been able to do the burden of disease analysis at the sub-national level.
7:58
So the first to ask for this was actually the United Kingdom.
8:04
And so then we did the burden of disease at local health authorities.
8:08
Soon thereafter, Mexico and Brazil and India and China Nigeria were added, Norway, New Zealand, and Brazil.
9:52
Can you think of a specific example where, because we were able to go deeper and to be more granular at the subnational level, there was something that was revealed that was especially useful to decision makers and maybe even help them to change or take a decision?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.